Literature DB >> 2461835

The insulin-like growth factors and their binding proteins.

R C Baxter1.   

Abstract

1. This review provides a brief overview of the structure of the insulin-like growth factors (IGFs or somatomedins), their mRNA and genes; the regulation and sites of production of these peptides; their binding and actions in target tissues; and the structure and biological role of their binding proteins. 2. Molecular cloning techniques have allowed the prediction of precursor forms of IGF-I and IGF-II, have provided tools to study the regulation of the synthesis and translation of IGF mRNAs, and have recently yielded the primary sequence of the IGF-I receptor, supplementing other rapidly-accumulating structural data. 3. Several of the IGF binding proteins have also been purified, and initial structural studies performed. 4. The increased knowledge of the structures of the IGFs, their receptors and binding proteins should now permit rapid progress in understanding the physiology and functions of these proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461835     DOI: 10.1016/0305-0491(88)90137-x

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  11 in total

Review 1.  Polypeptide growth factors and the kidney: a developmental perspective.

Authors:  E D Avner
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

2.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling.

Authors:  R C Baxter; J L Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.

Authors:  S Mohan; C M Bautista; J Wergedal; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Dexamethasone and 1,25(OH)2 vitamin D3 modulate the synthesis of insulin-like growth factor-I in osteoblast-like cells.

Authors:  T L Chen; J B Mallory; R L Hintz
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

5.  Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS).

Authors:  K Hanew; A Tanaka
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

6.  Collection of blood in heparinized tubes does not alter the molecular distribution or forms of IGFBP-3 and IGF.

Authors:  S Mandel; E Moreland; R G Rosenfeld; S E Gargosky
Journal:  Endocrine       Date:  1996-08       Impact factor: 3.633

7.  Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex.

Authors:  R C Baxter
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

8.  The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.

Authors:  S H Mandel; E Moreland; R G Rosenfeld; S E Gargosky
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

9.  Public health implications of bovine somatotropin use in dairying: discussion paper.

Authors:  T B Mepham
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000

10.  Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review.

Authors:  Ameer Khowaja; Brianna Johnson-Rabbett; John Bantle; Amir Moheet
Journal:  BMC Endocr Disord       Date:  2014-06-17       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.